Daniela Verthelyi

10PUBLICATIONS
55CO-AUTHORS
GlycoconjugatesInnate immunityNanotoxicology, health and safetyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 12, 2026
Proceedings of the 2024 FDA-CRCG Workshop: Scientific and Regulatory Considerations for Assessment of Immunogenicity Risk for Generic Peptide and Oligonucleotide Drug Products.

Jennifer K Lee, Ha-Na Lee, Sudhir Agrawal

|Jan 09, 2026
Multiplexed Immunophenotyping for Innate Activation Assessment Detects Single-Cell Responses to Immunomodulatory Nucleic Acid Impurities in Therapeutics.

Joseph A Balsamo, Mirian Mendoza, Logan Kelly-Baker

|Mar 10, 2025
CpG oligodeoxynucleotides and pan-serotype inhibitors control neurotropic dengue infection in novel immune competent neonatal mouse model.

Mirian Mendoza, Derek D C Ireland, Ha-Na Lee

|Dec 24, 2021
An In Vitro Assessment of Immunostimulatory Responses to Ten Model Innate Immune Response Modulating Impurities (IIRMIs) and Peptide Drug Product, Teriparatide.

Claire K Holley, Edward Cedrone, Duncan Donohue

|Oct 22, 2021
Characterization of the therapeutic effect of antibodies targeting the Ebola glycoprotein using a novel BSL2-compliant rVSVΔG-EBOV-GP infection model.

Ha-Na Lee, Ian L McWilliams, Aaron P Lewkowicz

|Mar 16, 2021
Lessons learned: new insights on the role of cytokines in COVID-19.

Maja Buszko, Aleksandra Nita-Lazar, Jung-Hyun Park

Pageof 2

Frequent Collaborators

3 joint publications

Seth G Thacker

3 joint publications

Logan Kelly-Baker

2 joint publications

Derek D C Ireland

2 joint publications

Jung-Hyun Park